Abemaciclib, dexamethasone, ixazomib, pomalidomide
MyDRUG (MMRC-085)
Phase 2 small_molecule completed
Quick answer
Abemaciclib, dexamethasone, ixazomib, pomalidomide for Relapsed Refractory Multiple Myeloma is a Phase 2 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Relapsed Refractory Multiple Myeloma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed